Cargando…
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from a Multi-Center, Open Label, Repeat Dose, Long Term Exposure, Year Long Phase II Safety Study
Autor principal: | Lorenc, Z. Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636565/ http://dx.doi.org/10.1097/01.GOX.0000526444.68948.f7 |
Ejemplares similares
-
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
por: Lorenc, Z. Paul
Publicado: (2017) -
Abstract: Treatment of Asymmetries and Sequelae of Facial Paralysis by Using Botulinum Toxin
por: Evin, Nuh, et al.
Publicado: (2017) -
Abstract: Long-Term Outcomes Following Flap Reconstruction in Pediatric Pressure Ulcers
por: Firriolo, Joseph M., et al.
Publicado: (2017) -
Abstract: 33 Condylar Fractures in 28 Children: Demographics, Treatment, Outcomes, and Long-Term Growth
por: Chen, Wendy, et al.
Publicado: (2017) -
Abstract: Diagnosis, Treatment, and LONG-TERM Speech Outcomes of Occult Submucous Cleft Palate-Associated Velopharyngeal Insufficiency
por: Brooker, Jack, et al.
Publicado: (2017)